Key facts
- It has raised $20K; the latest was Accelerator/Incubator ($20K) in Mar 2026.
- Notable investors include Husker Venture Fund, Lincoln Partnership for Economic Development.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Rheam Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Rheam Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rheam Medical
Developer of an automated trocar placement system designed to standardize and reduce risks during initial peritoneal access in minimally invasive surgery. The company integrates real-time visualization, advanced pressure sensing, and controlled insertion mechanisms to provide objective detection of peritoneal entry, deliver continuous feedback during abdominal access, support consistent trocar placement across laparoscopic and robotic procedures, and improve procedural precision and training processes, enabling surgeons and healthcare providers to enhance safety, reduce access-related complications, and achieve reliable surgical outcomes.
- Sector
- Healthcare
- HQ
- Lincoln, NE, United States
- Founded
- 2024
- Ownership
- Privately Held (backing)
Rheam Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rheam Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rheam Medical in its N-PORT filings yet. We sweep new filings monthly.